STOCK TITAN

Mirion Technologies (MIR) Stock News

MIR NYSE

Mirion Technologies, Inc. reports company developments in radiation detection, measurement, analysis and monitoring solutions for nuclear, medical, defense and research markets. Updates commonly cover financial results, orders, guidance, investor presentations and leadership appointments across the Nuclear & Safety and Medical groups.

Mirion's recurring business themes include nuclear power customers, critical radiation safety applications, R&D labs, nuclear facilities and healthcare uses such as Nuclear Medicine, Radiation Therapy QA, Occupational Dosimetry and Diagnostic Imaging. News also reflects the completed Paragon Energy Solutions acquisition, which added engineered nuclear-power offerings and is being integrated into the Nuclear & Safety group.

Rhea-AI Summary

Mirion (NYSE: MIR) will present at Baird’s 2026 Global Industrial Conference on November 10, 2026, at 5:05 PM ET. Chairman and Chief Executive Officer Thomas Logan and Chief Financial Officer and Medical Group President Brian Schopfer will present. A live webcast and an archived recording will be available through the Events and Presentations section of Mirion’s Investor Relations page.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.40%
Tags
none
-
Rhea-AI Summary

Mirion (NYSE: MIR) reported third-quarter revenue of $277.8 million, with higher earnings and orders alongside revisions to its full-year outlook. Revenue rose 24.5% year over year, while organic revenue grew 6.5%. GAAP net income increased to $7.8 million from $3.1 million, and GAAP earnings per share rose to $0.03 from $0.01. Adjusted EBITDA, an adjusted profit measure, increased 23.7% to $64.8 million.

Orders reached $386 million, up 85%; excluding Paragon and July results from Certrec, orders rose 62% to $340 million. Mirion now expects 2026 revenue growth of approximately 24%–25%, versus 22.0%–24.0% previously. It raised its adjusted free cash flow outlook to approximately $170 million–$185 million, but lowered adjusted EBITDA guidance to approximately $285 million–$292 million from $285 million–$300 million. Nine-month operating cash flow rose to $136.6 million from $70.3 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.70%
Tags
-
Rhea-AI Summary

Mirion (MIR) will release its third-quarter 2026 financial results after market close on Tuesday, October 27, 2026. The company will discuss the results on a conference call on Wednesday, October 28, 2026, at 10:00 am ET. A live webcast and subsequent replay will be available online.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.51%
Tags
conferences
Rhea-AI Summary

Mirion (NYSE: MIR) reported second quarter 2026 revenues of $266.8 million, up 19.7% from $222.9 million a year earlier. GAAP net income was $8.1 million, down 4.7% from $8.5 million, with GAAP diluted EPS of $0.03 versus $0.03–0.04 in 2025. Adjusted EBITDA rose 27.5% to $65.3 million from $51.2 million, and adjusted EPS increased to $0.12 from $0.11, with the current period including stock-based compensation expense.

Orders excluding the Certrec and Paragon acquisitions were $229 million, up 10%, while total orders including these acquisitions reached $291 million, up 40%. Operating cash flow for the first half of 2026 improved to $77.4 million from $48.0 million. Mirion reaffirmed full-year 2026 guidance, including total revenue growth of approximately 22–24%, organic revenue growth of 5–7%, adjusted EBITDA of $285–300 million (25–26% margin), adjusted free cash flow of $155–175 million (54–58% conversion), and adjusted EPS of $0.48–0.55 per share.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-13.22%
Tags
-
Rhea-AI Summary

Mirion (NYSE: MIR) will release its second quarter 2026 financial results after market close on Tuesday, July 28, 2026. The company will then host an earnings conference call on Wednesday, July 29, 2026 at 10:00 a.m. ET to discuss the results.

Investors can join the call by dialing 1-877-407-9208 (US toll-free) or 1-201-493-6784 and requesting the Mirion Technologies earnings call. A live webcast and an archived replay will be available on the Mirion investor relations website. A telephonic replay can be accessed at 1-844-512-2921 or 1-412-317-6671 using access code 13761513 until August 12, 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.25%
Tags
conferences
-
Rhea-AI Summary

Mirion (NYSE: MIR) reported Q1 2026 revenue of $257.6M, up 27.5% versus Q1 2025, and Adjusted EBITDA $54.3M, up 16.3% year-over-year. GAAP net loss was $3.4M for the quarter. Q1 orders were $241M excluding Paragon & Certrec and $288M including those acquisitions. The company reaffirmed full-year 2026 revenue, Organic revenue, Adjusted EBITDA, and Adjusted free cash flow guidance, and revised Adjusted EPS guidance to $0.48–$0.55 to reflect a special one-time CEO retention grant.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.11%
Tags
Rhea-AI Summary

Mirion (NYSE: MIR) will release first quarter 2026 financial results after market close on Tuesday, April 28, 2026. The company will host an earnings conference call on Wednesday, April 29, 2026 at 10:00 am ET with a live webcast and telephonic replay available through May 13, 2026.

Dial-in numbers, replay access codes, and webcast links are provided for investors and analysts to listen live or via archived replay on the company investor website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.48%
Tags
conferences
-
Rhea-AI Summary

Mirion (NYSE: MIR) said Chairman and CEO Thomas Logan and CFO and Medical Group President Brian Schopfer will present at Citi’s 2026 Global Industrial Tech and Mobility Conference on Wednesday, February 18, 2026 at 2:40 PM ET. The presentation will be webcast live and archived on the company's Investor Relations page.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.80%
Tags
none
-
Rhea-AI Summary

Mirion (NYSE: MIR) announced three senior appointments on February 11, 2026 to accelerate strategic growth: Tighe Smith is promoted to the newly created Chief Nuclear Officer, Shelia Webb becomes President, Nuclear Medicine, and Shahmeer Mirza is named inaugural Chief Artificial Intelligence & Digital Officer.

All three report to CEO Thomas Logan and will lead global nuclear strategy, nuclear medicine integration (including ec2 Software and Capintec) and enterprise AI/digital transformation. Mirion solutions serve over 98% of nuclear power plants and >6,000 cancer centers worldwide.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.20%
Tags
none
Rhea-AI Summary

Mirion (NYSE:MIR) reported Q4 2025 revenue of $277.4M (+9.1% YoY) and GAAP net income of $17.8M (+11.9% YoY). Adjusted EBITDA for the quarter was $77.6M (+11.5%). For fiscal 2026 the company guides total revenue growth of 22.0%–24.0%, organic revenue growth of 5.0%–7.0%, adjusted EBITDA of $285M–$300M, adjusted free cash flow of $155M–$175M, and adjusted EPS of $0.50–$0.57.

Management noted over $1 billion of orders in 2025 and expects full-year contributions from Paragon Energy Solutions and Certrec in 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.20%
Tags

FAQ

What is the current stock price of Mirion Technologies (MIR)?

Mirion Technologies (MIR) last closed at $17.04.

What is the market cap of Mirion Technologies (MIR)?

The market cap of Mirion Technologies (MIR) is approximately $4.2B.